Drug intelligence / Profile preview

Tuxil

Development stage
Unknown
Lead developer
Fidson HealthCare
Modality
Small Molecules
Administration
Oral
01

Overview

Tuxil is a brand of cough and cold remedies developed and manufactured by Fidson Healthcare Plc, a Nigerian pharmaceutical company. The product line includes multiple formulations designed for different symptomatic needs. **Tuxil-D** is a non-sedative daytime preparation containing cetirizine hydrochloride (an antihistamine), ammonium chloride (an expectorant), sodium citrate (a mucolytic and buffering agent), ephedrine hydrochloride (a decongestant), and menthol. **Tuxil-N** is a sedative nighttime formulation containing ephedrine, chlorphenamine (a sedating antihistamine), ammonium chloride, and sodium citrate. These products are marketed as branded generics for the treatment of cough, common cold, fever, allergies, and bronchial congestion. They work by loosening phlegm, clearing respiratory passages, and providing relief from allergic symptoms.

Brand names
TuxilTuxil-DTuxil-N
02

Targets

HRH1 (Histamine H1 Receptor)NMDAR (Glutamate receptor ionotropic, NMDA)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)COX

Beyond the preview

Go deeper on Tuxil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuxil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call